171 related articles for article (PubMed ID: 36129954)
41. Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma.
Bousquet G; El Bouchtaoui M; Leboeuf C; Battistella M; Varna M; Ferreira I; Plassa LF; Hamdan D; Bertheau P; Feugeas JP; Damotte D; Janin A
Oncotarget; 2015 Aug; 6(22):19279-89. PubMed ID: 26002555
[TBL] [Abstract][Full Text] [Related]
42. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB
Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597
[TBL] [Abstract][Full Text] [Related]
43. Positron emission tomography for prostate, bladder, and renal cancer.
Schöder H; Larson SM
Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
[TBL] [Abstract][Full Text] [Related]
44. Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review.
Kierney PC; van Heerden JA; Segura JW; Weaver AL
Ann Surg Oncol; 1994 Jul; 1(4):345-52. PubMed ID: 7850534
[TBL] [Abstract][Full Text] [Related]
45. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases.
Torres L; Ribeiro FR; Pandis N; Andersen JA; Heim S; Teixeira MR
Breast Cancer Res Treat; 2007 Apr; 102(2):143-55. PubMed ID: 16906480
[TBL] [Abstract][Full Text] [Related]
46. The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ.
Kakizoe M; Yao M; Tateishi U; Minamimoto R; Ueno D; Namura K; Makiyama K; Hayashi N; Sano F; Kishida T; Kobayashi K; Noguchi S; Ikeda I; Ohgo Y; Taguri M; Morita S; Inoue T; Kubota Y; Nakaigawa N
BMC Cancer; 2014 Jun; 14():390. PubMed ID: 24885730
[TBL] [Abstract][Full Text] [Related]
47. Survival of brain metastatic patients in Yazd, Iran.
Akhavan A; Binesh F; Heidari S
Asian Pac J Cancer Prev; 2014; 15(8):3571-4. PubMed ID: 24870759
[TBL] [Abstract][Full Text] [Related]
48. Renal cell carcinoma metastatic to the pancreas: results of surgical management.
Sohn TA; Yeo CJ; Cameron JL; Nakeeb A; Lillemoe KD
J Gastrointest Surg; 2001; 5(4):346-51. PubMed ID: 11985973
[TBL] [Abstract][Full Text] [Related]
49. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
Paolino G; Panetta C; Didona D; Donati M; Donati P
Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
[TBL] [Abstract][Full Text] [Related]
50. Metastases to the thyroid gland: seventeen cases operated on in a single clinical center.
Cichoń S; Anielski R; Konturek A; Barczyński M; Cichoń W
Langenbecks Arch Surg; 2006 Nov; 391(6):581-7. PubMed ID: 16983577
[TBL] [Abstract][Full Text] [Related]
51. Clinical Response to Immunotherapy Targeting Programmed Cell Death Receptor 1/Programmed Cell Death Ligand 1 in Patients With Treatment-Resistant Microsatellite Stable Colorectal Cancer With and Without Liver Metastases.
Wang C; Sandhu J; Ouyang C; Ye J; Lee PP; Fakih M
JAMA Netw Open; 2021 Aug; 4(8):e2118416. PubMed ID: 34369992
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization.
Bissig H; Richter J; Desper R; Meier V; Schraml P; Schäffer AA; Sauter G; Mihatsch MJ; Moch H
Am J Pathol; 1999 Jul; 155(1):267-74. PubMed ID: 10393858
[TBL] [Abstract][Full Text] [Related]
53. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter.
Remzi M; Ozsoy M; Klingler HC; Susani M; Waldert M; Seitz C; Schmidbauer J; Marberger M
J Urol; 2006 Sep; 176(3):896-9. PubMed ID: 16890647
[TBL] [Abstract][Full Text] [Related]
54. Molecular genetic differentiation between primary lung cancers and lung metastases of other tumors.
Kandioler D; Dekan G; End A; Pasching E; Buchmayer H; Gnant M; Langmann F; Mannhalter C; Eckersberger F; Wolner E
J Thorac Cardiovasc Surg; 1996 Apr; 111(4):827-31; discussion 832. PubMed ID: 8614143
[TBL] [Abstract][Full Text] [Related]
55. Genetic characterization of lung metastases in renal cell carcinoma.
Junker K; Sänger J; Schmidt A; Hindermann W; Presselt N; Helfritzsch H; Schubert J
Oncol Rep; 2003; 10(4):1035-8. PubMed ID: 12792766
[TBL] [Abstract][Full Text] [Related]
56. The effect of biological effective dose on time to symptom progression in metastatic renal cell carcinoma.
Wilson D; Hiller L; Gray L; Grainger M; Stirling A; James N
Clin Oncol (R Coll Radiol); 2003 Oct; 15(7):400-7. PubMed ID: 14570088
[TBL] [Abstract][Full Text] [Related]
57. What Is the Clinical Importance of Incidental Findings on Staging CT Scans in Patients With Sarcoma?
Mayo Z; Kennedy S; Gao Y; Miller BJ
Clin Orthop Relat Res; 2019 Apr; 477(4):730-737. PubMed ID: 30601764
[TBL] [Abstract][Full Text] [Related]
58. [Surgical management of pulmonary metastases].
Hara S; Otsuka H; Hirohata T; Nishi K; Yasutomi M
Nihon Geka Gakkai Zasshi; 1998 Dec; 99(12):855-60. PubMed ID: 10063499
[TBL] [Abstract][Full Text] [Related]
59. [Radiosensitivity of bone metastases from tumors in different primary sites].
Khmelevsky EV; Bychkova NM
Vopr Onkol; 2015; 61(1):77-84. PubMed ID: 26016150
[TBL] [Abstract][Full Text] [Related]
60. Comparison of Percutaneous Image-Guided Microwave Ablation and Cryoablation for Sarcoma Lung Metastases: A 10-Year Experience.
Bourgouin PP; Wrobel MM; Mercaldo ND; Murphy MC; Leppelmann KS; Levesque VM; Muniappan A; Silverman SG; Shepard JO; Shyn PB; Fintelmann FJ
AJR Am J Roentgenol; 2022 Mar; 218(3):494-504. PubMed ID: 34612679
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]